Summary
Four experiments investigating the antitumor activity of bacterial lipopolysaccharide (LPS) against the autochthonous methylnitrosourea — induced mammary carcinoma are summarized. Administration of LPS alone i.v. caused distinct regression of small tumors following its first injection. This therapeutic effect, however, was short-lived and could not be maintained by administering a second dose. The observed antineoplastic activity of LPS was dose-related, whereas no dose-response relationship was observed with respect to its toxicity. A series of experiments in which LPS was combined with other compounds to possibly exploit its activity while reducing the toxicity were performed. Neither the combination with cytotoxic drugs such as 4′-(9-acridinylamino.)-methansulfone-m-aniside or cyclophosphamide nor that will 1-octadecyl-2-methoxy-rac-glycero-3-phosphocholine or hexadecylphosphocholine showed sufficient anticancer activity at acceptable toxicity. In all experiments promising efficacy was observed at high dosages but also high toxicity. When the dosages were reduced, diminished antineoplastic activity was found together with overproportionally high mortality. It might therefore be concluded that the active dose range of LPS cannot be reached clinically because of its inherent toxicity.
Similar content being viewed by others
References
Abe S, Yoshioka O, Masuko Y, Tsubouchi J, Kohno M, Nakajiama H, Yamazaki M, Mizono D (1982a) Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors. Gann 73:91–96
Abe S, Tsubouchi J, Takahashi K, Yamazaki M, Mizuno D (1982b) Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide. Gann 73:961–967
Berger M, Zeller J (1984) Wege zur rationalen präklinischen Testung antineoplastischer Chemotherapeutika, Bd 18. In: Beitr Onkologie. Karger, Basel, S. 274–286
Berger M, Habs M, Schmähl D (1983) Noncarinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats. Int J Cancer 32:231–236
Berger M, Floride J, Schreiber J, Schmähl D, Eisenbrand G (1984a) Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. J Cancer Res Clin Oncol 108:148–153
Berger M, Munder P, Schmähl D, Westphal O (1984b) Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammar carcinomas. Oncology 41:109–113
Berger M, Floride J, Schmähl D, Schreiber J, Eisenbrand G (1986a) Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions. Eur J Cancer Clin Oncol 22:1179–1191
Berger M, Schmähl D, Muschiol C, Unger C, Eibl H (1986b) Alkylphosphocholines as anticancer agents. J Cancer Res Clin Oncol 111:24
Drews J (1984) Immunostimulation. Klin Wochenschr 62:254–264
Eibl H, Unger C, Fleer E, Kim D, Berger M, Nagel G (1986) Hexadecylphosphocholine, a new antineoplastic agent: cytotoxic properties in leukaemic cells. J Cancer Res Clin Oncol 111:24
Eichelberg D, Schmutzler W (1983) Pharmakologische Aspekte der Immunstimulanzien. Immun Infekt 11:109–122
Galanos C, Lüderitz O, Rietschel E, Westphal O (1977) Newer aspects of the chemistry and biology of bacterial lipopolysaccharides with special reference to their lipid A component. In: Goodwin T (ed) Biochemistry of lipids II, vol 14. University Park Press, Baltimore, pp 239–335
Galanos C, Lüderitz O, Westphal O (1979) Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi. Zentralbl Bakt Hyg I Abt Orig A 243:226–244
Habs M (1985) Tierexperimentelle Studien zum Wirksamkeitsnachweis und zur Verträglichkeit biologisch aktiver Substanzen. In: Schuff-Werner P, Pfitzenmaier K (Hrsg) Aktuelle Onkologie Bd 24. Zuckschwerdt, München Bern Wien, S 43–51
Haranaka K, Satomi N, Sakurai A, Kunii O (1984) Role of lilip A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis factor and lipopolysaccharide. Tohoku J Exp Med 144:385–396
Hasegawa T, Ohta M, Kido N, Kato N, Miyamoto K, Koshiura R (1985) Comparative studies on antitumor activity of Klebsiella O3 lipopolysaccharide and its polysaccharide fraction in mice. Jpn J Pharmacol 38:355–360
Izui S, Morrison D, Curry B, Dixon J (1980) Effect of lipid A — associated protein and lipid A on the expression of lipopolysaccharide activity. Immunology 40:473–482
Kalbfleisch JD, Prentice RL (1979) The statistical analysis of failure rime data. Wiley, New York
Kodama M, Mizukuro T, Yamaguchi N, Yoshida S, Katayama Y (1982) The mechanism of antitumor activity of bacterial endotoxins. In: Jelijaszewicz J, Pulverer G, Roszkowski J (eds) Bacteria and cancer. Academic Press, London, pp 167–179
Koziol AJ, Donna AM (1981) A distribution free test for tumor growth curve analysis with application to an animal tumor immunotherapy experiment. Biometrics 37:383–390
Miyamoto K, Koshiura R, Hasegawa T, Kato N (1984) Antitumor activity of Klebsiella 03 lipopolysaccharide in mice. Jpn J Pharmacol 36:51–57
Mizuno D, Yoshioka O, Akamatu M, Kataoka T (1968) Antitumor effect of intracutaneous injection of bacterial lipopolysaccharide. Cancer Res 28:1531–1537
Nagel G (1985) Grundlagen, der Immunologie maligner Tumoren. In: Brunner K, Nagel G (Hrsg) Internistische Krebstherapie, 3. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 154–158
Newburger P, Hamaoka T, Katz D (1974) Potentiation of helper T cell function in IgE antibody responses by bacterial lipopolysaccharide (LPS). J Immunol 113:824–829
Oldham R, Fidler I, Talmadge J (1985) Screening of biologicals and biological response modifiers. In: Schuff-Werner P, Pfitzenmaier K (Hrsg) Aktuelle Onkologie, Bd 24. Zuckschwerdt, München Bern Wien, S 93–109
Ribi E, Granger D, Milner K, Strain M (1975) Brief communication: tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst 55:1253–1257
Schmähl D (1981) Maligne Tumoren. Editio Cantor Aulendorf
Schmähl D, Osswald H, Brune H (1966) Chemotherapie — Versuche mit Endoxan an autochthonen Benzpyren — Sarkomen bei Ratten und Mäusen. Z Krebsforsch 68:293–302
Sedlacek H, Dickneite G, Schorlemmer H (1985) Präklinische Prüfung von Immunmodulatoren unter spezieller Berücksichtigung von Chemoimmunotherapeutika. In: Schuff-Werner P, Pfitzenmaier K (Hrsg) Aktuelle Onkologie, Bd 24. Zuckschwerdt, München Bern Wien, S 53–78
Vosika G, Barr C, Gilbertson D (1984) Phase I — study of intravenous modified lipid A. Cancer Immunol Immunother 18:107–112
Westphal O, Westphal U, Sommer T (1977) History of pyrogenic research. In: Schlesinger D (ed) Microbiology 1977. Am Soc of Microbiology, Washington, pp 221–238
Zeller J, Berger M (1984) Chemically induced autochthonous tumor models in experimental chemotherapy. Behring Inst Mitt 74:201–208
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berger, M.R., Petru, E. & Schmähl, D. Therapeutic ratio of mono or combination bacterial lipopolysaccharide therapy in methylnitrosourea — induced rat mammary carcinoma. J Cancer Res Clin Oncol 113, 437–445 (1987). https://doi.org/10.1007/BF00390037
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00390037